Renovaro Biosciences Company Insiders

RENB Stock   0.77  0.07  8.33%   
Renovaro Biosciences employs about 25 people. The company is managed by 11 executives with a total tenure of roughly 59 years, averaging almost 5.0 years of service per executive, having 2.27 employees per reported executive. Analysis of Renovaro Biosciences' management performance can provide insight into the company performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renovaro Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.

Renovaro Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.1809) % which means that it has lost $0.1809 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8847) %, meaning that it created substantial loss on money invested by shareholders. Renovaro Biosciences' management efficiency ratios could be used to measure how well Renovaro Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.

Renovaro Biosciences Workforce Comparison

Renovaro Biosciences is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 13,907. Renovaro Biosciences adds roughly 25.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Renovaro Biosciences Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Renovaro Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Renovaro Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Renovaro Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Renovaro Biosciences Notable Stakeholders

A Renovaro Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Renovaro Biosciences often face trade-offs trying to please all of them. Renovaro Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Renovaro Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Serhat GmrkcCoFounder InventorProfile
David WeinsteinCEO DirectorProfile
Mark MDDirector CEOProfile
Hon MDDirector CEOProfile
Luisa PucheCFO SecretaryProfile
Greg DuczynskiSenior OperationsProfile
Simon TarshInterim OfficerProfile
Nathen CPAChief OfficerProfile
Francois MScExecutive DevelopmentProfile
Evelyn DAnConsultantProfile
Franois MScEx RDProfile

About Renovaro Biosciences Management Performance

The success or failure of an entity such as Renovaro Biosciences often depends on how effective the management is. Renovaro Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Renovaro management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Renovaro management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of Renovaro Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Renovaro Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Renovaro Biosciences' management manipulating its earnings.

Renovaro Biosciences Workforce Analysis

Traditionally, organizations such as Renovaro Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Renovaro Biosciences within its industry.

Renovaro Biosciences Manpower Efficiency

Return on Renovaro Biosciences Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee3.2M
Net Loss Per Executive7.3M

Complementary Tools for Renovaro Stock analysis

When running Renovaro Biosciences' price analysis, check to measure Renovaro Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renovaro Biosciences is operating at the current time. Most of Renovaro Biosciences' value examination focuses on studying past and present price action to predict the probability of Renovaro Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renovaro Biosciences' price. Additionally, you may evaluate how the addition of Renovaro Biosciences to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency